RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2014; 46(11): 1469-1474
DOI: 10.1055/s-0033-1338609
DOI: 10.1055/s-0033-1338609
paper
Synthesis of Pyridoacridines through Anionic Cascade Ring Closure
Weitere Informationen
Publikationsverlauf
Received: 28. Januar 2014
Accepted after revision: 21. Februar 2014
Publikationsdatum:
21. März 2014 (online)
Abstract
A new synthesis of 13-deazaascididemin (AK-37) based on a recently developed anionic cascade ring closure is presented. Although the isolated yields are modest, the approach provides ready access to new substituted derivatives of 13-deazaascididemin.
Key words
fused ring systems - natural products - cross coupling - anionic cascade ring closure - oxidationSupporting Information
- for this article is available online at http://www.thieme-connect.com/ejournals/toc/synthesis. Included are copies of 1H and 13C NMR spectra.
- Supporting Information
-
References
- 1 Marshall KM, Barrows LR. Nat. Prod. Rep. 2004; 21: 731
- 2 Kobayashi J, Cheng J, Nakamura H, Ohizumi Y, Hirata Y, Sasaki T, Ohta T, Nozoe S. Tetrahedron Lett. 1988; 29: 1177
- 3a Molinski TF. Chem. Rev. 1993; 93: 1825
- 3b Delfourne E, Kiss R, Le Corre L, Merza J, Bastide J, Frydman A, Darro F. Bioorg. Med. Chem. 2003; 11: 4351
- 3c Delfourne E, Kiss R, Le Corre L, Dujols F, Bastide J, Collignon F, Lesur B, Frydman A, Darro F. Bioorg. Med. Chem. 2004; 12: 3987
- 3d Belmont P, Bosson J, Godet T, Tiano M. Anticancer Agents Med. Chem. 2007; 7: 139
- 3e Boiffier L, Gosse I, Demenuynck M, Mailley P. Bioelectrochemistry 2012; 88: 103
- 4a Bracher F. Heterocycles 1989; 29: 2093
- 4b Cuerva JM, Cardenas DJ, Echavarren AM. J. Chem. Soc., Perkin Trans. 1 2002; 1360
- 4c Cuerva JM, Cardenas DJ, Echavarren AM. Chem. Commun. 1999; 1721
- 4d Gellerman G, Rudi A, Kashman Y. Synthesis 1994; 239
- 4e Moody CJ, Rees CW, Thomas R. Tetrahedron 1992; 48: 3589
- 4f Alvarez M, Feliu L, Ajana W, Joule JA, Fernández-Puentes JL. Eur. J. Org. Chem. 2000; 849
- 4g Delfourne E, Bastide J. Med. Res. Rev. 2003; 23: 234
- 5 Marshall KM, Holden JA, Koller A, Kashman Y, Copp BR, Barrows LR. Anti-Cancer Drugs 2004; 15: 907
- 6a Peterson JR, Zjawiony JK, Liu S, Hufford CD, Clark AM, Rogers RD. J. Med. Chem. 1992; 35: 4069
- 6b Raeder S, Bracher F. Arch. Pharm. 2012; 345: 822
- 6c Koller A, Rudi A, Gravalos MG, Kashman Y. Molecules 2001; 6: 300
- 6d Lindsay BS, Pearce AN, Copp BR. Synth. Commun. 1997; 27: 2587
- 7a Petersen IN, Crestey F, Kristensen JL. Chem. Commun. 2012; 48: 9092
- 7b Kristensen JL, Vedsø P, Begtrup M. J. Org. Chem. 2003; 68: 4091
- 7c Kristensen JL. Tetrahedron Lett. 2008; 49: 2351
- 8a Battino R, Rettich TR, Tominaga T. J. Phys. Chem. Ref. Data 1983; 12: 163
- 8b Dias AM. A, Bonifácio RP, Marrucho IM, Pádua AA. H, Gomes MF. C. Phys. Chem. Chem. Phys. 2003; 5: 543
- 9 Øpstad CL, Melø T.-B, Sliwka H.-R, Partali V. Tetrahedron 2009; 65: 7616
- 10a Hepburn SA, Jackson YA. Heterocycles 2006; 68: 975
- 10b Plodek A, Reader S, Bracher F. Tetrahedron 2013; 69: 9857
- 11 Iida T, Wada T, Tomimoto K, Mase T. Tetrahedron Lett. 2001; 42: 4841
- 12a Carroll AR, Scheuer PJ. J. Org. Chem. 1990; 55: 4426
- 12b Kitahara Y, Nakahara S, Yonezawa T, Nagatsu M, Shibano Y, Kubo A. Heterocycles 1993; 36: 943
- 12c Lindsay BS, Pearce AN, Copp BR. Synth. Commun. 1997; 27: 2587
- 12d Kitahara Y, Nakahara S, Yonezawa T, Nagatsu M, Shibano Y, Kubo A. Tetrahedron 1997; 53: 17029
- 13 Shen K, Fu Y, Li J, Liu L, Guo Q. Tetrahedron 2007; 63: 1568
- 14 Nishi H, Numains T, Kobatake S. J. Mater. Chem. 2001; 21: 17249
- 15 Dondoni A, Fantin G, Fogagnolo M, Medici A, Pedrini P. J. Org. Chem. 1988; 53: 1748
- 16 Burchat AF, Chong JM, Nielsen N. J. Organomet. Chem. 1997; 542: 281
For a related anionic cascade ring closure, see:
For the isolation and structure elucidation of kuanoniamine A, see:
For synthetic efforts, see: